Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Structure and potential role of T6SS effector PdpC in Francisella tularensis intracellular lifestyle.

Communications biology·2026

Same author

Discovery and cryoEM structure of FPM13, a periplasmic metalloprotein unique to Francisella.

PLoS pathogens·2026

Same author

Discovery and CryoEM Structure of FPM13, a Periplasmic Metalloprotein Unique to <i>Francisella</i>.

bioRxiv : the preprint server for biology·2025

Same author

Atomic Structure and Phospholipid Binding Properties of the <i>Francisella</i> Type VI Secretion System Effector Protein PdpC.

bioRxiv : the preprint server for biology·2025

Same author

Universal Bacterium-Vectored COVID-19 Vaccine Expressing Early SARS-CoV-2 Conserved Proteins Cross-Protects Against Late Variants in Hamsters.

Vaccines·2025

Same author

Adding Intranasal to Oral Administration of an Ultra-Rapid Near-Universal Drug Regimen Accelerates Relapse-Free Cure of Tuberculosis in Mice.

The Journal of infectious diseases·2025

Search research articles

Related Experiment Video

Updated: Mar 3, 2026

Synthesis, Functionalization, and Characterization of Fusogenic Porous Silicon Nanoparticles for Oligonucleotide Delivery

Synthesis, Functionalization, and Characterization of Fusogenic Porous Silicon Nanoparticles for Oligonucleotide Delivery

Published on: April 16, 2019

A Pathogen-Specific Cargo Delivery Platform Based on Mesoporous Silica Nanoparticles.

Bastian Ruehle¹, Daniel L Clemens¹, Bai-Yu Lee¹

¹Department of Chemistry and Biochemistry, ‡California NanoSystems Institute, and §Division of Infectious Diseases, Department of Medicine, University of California , Los Angeles, California 90095, United States.

Journal of the American Chemical Society

|April 25, 2017

Summary

We developed a novel nanovalve system that precisely targets Francisella tularensis bacteria. This platform ensures pathogen-specific drug delivery, minimizing harm to healthy tissues.

More Related Videos

Porous Silicon Microparticles for Delivery of siRNA Therapeutics

Porous Silicon Microparticles for Delivery of siRNA Therapeutics

Published on: January 15, 2015

Manufacture and Drug Delivery Applications of Silk Nanoparticles

Manufacture and Drug Delivery Applications of Silk Nanoparticles

Published on: October 8, 2016

Related Experiment Videos

Last Updated: Mar 3, 2026

Synthesis, Functionalization, and Characterization of Fusogenic Porous Silicon Nanoparticles for Oligonucleotide Delivery

Synthesis, Functionalization, and Characterization of Fusogenic Porous Silicon Nanoparticles for Oligonucleotide Delivery

Published on: April 16, 2019

Porous Silicon Microparticles for Delivery of siRNA Therapeutics

Porous Silicon Microparticles for Delivery of siRNA Therapeutics

Published on: January 15, 2015

Manufacture and Drug Delivery Applications of Silk Nanoparticles

Manufacture and Drug Delivery Applications of Silk Nanoparticles

Published on: October 8, 2016

Area of Science:

Biotechnology
Nanotechnology
Microbiology

Background:

Francisella tularensis is a Tier 1 Select Agent posing significant bioterrorism risks.
Current infectious disease treatments can cause off-target toxicities due to broad drug release.
Targeted delivery systems are needed to improve treatment efficacy and reduce side effects.

Purpose of the Study:

To develop a pathogen-selective detection and delivery platform for Francisella tularensis.
To demonstrate pathogen-specific cargo release using antibody-functionalized nanovalves.
To minimize off-target toxicities in infectious disease treatment.

Main Methods:

Utilized antibody nanovalves interacting with a specific tetrasaccharide on Francisella tularensis lipopolysaccharide (LPS).
Engineered mesoporous silica nanoparticles for controlled cargo release.
Validated specificity by comparing cargo release triggered by F. tularensis LPS versus Pseudomonas aeruginosa LPS.
Confirmed specificity using live F. tularensis bacteria versus the related Francisella novocida.

Main Results:

Achieved highly specific cargo release from nanovalves in the presence of F. tularensis.
Demonstrated selective release of a signal transducer and a model drug.
Confirmed specificity against a non-target pathogen (P. aeruginosa) and a closely related bacterium (F. novocida).

Conclusions:

The antibody nanovalve platform shows proof-of-concept for pathogen-specific detection and drug delivery.
This technology offers a promising approach for targeted treatment of bioterrorism agents like F. tularensis.
Potential applications extend to general infectious disease treatment, improving safety and efficacy.